Regulated cell death (RCD) encompasses genetically encoded and pharmacologically modifiable pathways that govern cellular demise. In the nervous system, RCD assumes unique biological and clinical relevance due to neurons’ post-mitotic status, the functional integration of neural circuits, and the central role of glial cells in homeostasis and inflammation. This review synthesizes current knowledge on apoptotic and non-apoptotic RCD modalities in neurons and glia, integrates molecular mechanisms with ultrastructural hallmarks, and discusses specific patterns of pathway engagement. We emphasize compartmentalized death, pathway crosstalk, and cell-type specificity.
No takes yet. Share an insight, caveat, or question.
Lossi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: